The Palomero group found that transcriptional downregulation of PTEN mediates physiologic upregulation of the PI3K-AKT pathway; mutational loss of PTEN and aberrant Akt activation induce resistance to GSI in T-cell leukemia [124]. This evidence concerns the gene AKT1 and T-cell leukemia.